Skip to main content

Erythema

9
Pipeline Programs
8
Companies
13
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
5
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
3 programs
1
1
BAY207543Phase 41 trial
Dexpanthenol foam spray, new formulationPhase 21 trial
BAY207543N/A1 trial
Active Trials
NCT03852563Completed33Est. Apr 2019
NCT00839462Completed55Est. Sep 2007
NCT03853538Completed33Est. Mar 2019
AbbVie
AbbVieNORTH CHICAGO, IL
3 programs
3
AGN-199201Phase 31 trial
Oxymetazoline HCL Cream 1.0%Phase 31 trial
Oxymetazoline HCL Cream 1.0%Phase 31 trial
Active Trials
NCT02131636Completed440Est. Dec 2014
NCT02095158Completed440Est. Sep 2015
NCT02132117Completed445Est. May 2015
Galderma
GaldermaTX - Dallas
2 programs
2
CD07805/47 Gel 0.5%Phase 31 trial
CD07805/47 gel 0.5%/CD07805/47 VehiclePhase 31 trial
Active Trials
NCT01882712Withdrawn0
NCT01659853Completed70Est. Dec 2012
Moberg Pharma
Moberg PharmaSweden - Stockholm
2 programs
2
MOB015BPhase 11 trial
MOB015BPhase 11 trial
Active Trials
NCT06369675Completed45Est. Nov 2017
NCT06369727Completed250Est. Feb 2018
Biocorp
BiocorpFrance - Issoire
1 program
CB-0002BN/A
CAGE Bio
CAGE BioCA - San Carlos
1 program
CB-0002BN/A1 trial
Active Trials
NCT04498676Completed50Est. Mar 2017
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Pomegranate JuiceN/A1 trial
Active Trials
NCT03496584Terminated35Est. Feb 2021
Omeza
OmezaFL - Sarasota
1 program
Test ArticleN/A1 trial
Active Trials
NCT04510675Completed58Est. Jan 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerBAY207543
AbbVieOxymetazoline HCL Cream 1.0%
AbbVieAGN-199201
AbbVieOxymetazoline HCL Cream 1.0%
GaldermaCD07805/47 gel 0.5%/CD07805/47 Vehicle
BayerDexpanthenol foam spray, new formulation
Moberg PharmaMOB015B
Moberg PharmaMOB015B
OmezaTest Article
BayerBAY207543
Angeles TherapeuticsPomegranate Juice
CAGE BioCB-0002B

Clinical Trials (13)

Total enrollment: 1,954 patients across 13 trials

NCT03853538BayerBAY207543

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering

Start: Jan 2019Est. completion: Mar 201933 patients
Phase 4Completed
NCT01882712GaldermaCD07805/47 Gel 0.5%

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema

0
Phase 3Withdrawn
NCT02132117AbbVieOxymetazoline HCL Cream 1.0%

Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea

Start: Jun 2014Est. completion: May 2015445 patients
Phase 3Completed
NCT02131636AbbVieAGN-199201

Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea

Start: May 2014Est. completion: Dec 2014440 patients
Phase 3Completed
NCT02095158AbbVieOxymetazoline HCL Cream 1.0%

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

Start: Apr 2014Est. completion: Sep 2015440 patients
Phase 3Completed
NCT01659853GaldermaCD07805/47 gel 0.5%/CD07805/47 Vehicle

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Start: Sep 2012Est. completion: Dec 201270 patients
Phase 3Completed
NCT00839462BayerDexpanthenol foam spray, new formulation

Efficacy of Dexpanthenol in Thermic Erythema

Start: Sep 2007Est. completion: Sep 200755 patients
Phase 2Completed
NCT06369675Moberg PharmaMOB015B

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design

Start: Oct 2017Est. completion: Nov 201745 patients
Phase 1Completed
NCT06369727Moberg PharmaMOB015B

Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design

Start: Oct 2017Est. completion: Feb 2018250 patients
Phase 1Completed
NCT04510675OmezaTest Article

Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT

Start: Dec 2019Est. completion: Jan 202058 patients
N/ACompleted
NCT03852563BayerBAY207543

A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering

Start: Mar 2019Est. completion: Apr 201933 patients
N/ACompleted
NCT03496584Angeles TherapeuticsPomegranate Juice

Effects of Phytonutrients on Vascular Health and Skin in Obese Males

Start: Mar 2018Est. completion: Feb 202135 patients
N/ATerminated
NCT04498676CAGE BioCB-0002B

50 Human Subject Repeat Insult Patch Test

Start: Jan 2017Est. completion: Mar 201750 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 late-stage (Phase 3) programs, potential near-term approvals
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.